Mid Europa buys Teresa Fryda Laboratory
Mid Europa Partners has acquired Dr. n. med. Teresa Fryda Laboratorium Medyczne Sp. Z o.o. (“Fryda”) as part of its plans to consolidate the Polish laboratory market.
The transaction was carried out through newco Polska Grupa Laboratoriów Medycznych Sp. Z o.o ("Polska Grupa Laboratoriów").
Investment will support Fryda's expansion in the Polish laboratory market, following Polska Grupa Laboratoriów's acquisition of a strategic stake in laboratory services provider Diagnostyka Sp. Z o.o. ("Diagnostyka") in January this year.
Company
Established in 1989, Fryda offers laboratory diagnostics services to hospitals, private clinics and individuals. In 2010, the company performed around 10 million tests in over 30 laboratories across Poland. Fryda has around 200 staff specialising in microbiology and medical analysis.
People
Pawel Padusińki is a director at Mid Europa Partners and led the transaction alongside Jan Krzewiński. Teresa Fryda is founder and CEO of Fryda. Jakub Swadźba is co-founder of Diagnostyka.
Advisers
Equity - PwC (Financial due dilligence), Weil Gotshal & Manges (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








